1.
c-Abl Stabilizes Estrogen Receptor by Phosphorylation and Regulates Its Transcription Activity;
c-Abl非受体酪氨酸激酶调节ERα转录活性的研究
2.
The Study on the Transcripition Activity Modulation of C/EBPβ by c-Abl Non-Receptor Tyrosine Kinase;
c-Abl非受体酪氨酸激酶调节C/EBPβ转录活性的研究
3.
Functional Interaction between HAX-1 and c-Abl Non-receptor Tyrosine Kinase;
HAX-1与c-Abl非受体酪氨酸激酶相互作用及其生物学意义
4.
Functional Interaction between c-Abl Non-receptor Tyrosine Kinase and FHL2
c-Abl非受体酪氨酸激酶与FHL2相互作用及其生物学意义
5.
Expression of receptor tyrosine kinase EphA1 in gastric cancer and its clinicopathological significance
受体酪氨酸激酶EphA1 mRNA在胃癌中的表达
6.
Expression and Clinical Significance of Receptor Tyrosine Kinase RON in Lung Carcinoma
肺癌组织中酪氨酸激酶受体RON的表达及意义
7.
Molecular targeted therapies:targeting receptor tyrosine kinases in the treatment of gastric cancer
靶向于受体酪氨酸激酶的胃癌分子靶向治疗
8.
Advances in the inhibitors of FLT-3 receptor tyrosine kinase
FLT-3受体酪氨酸激酶抑制剂的研究进展
9.
Expression of receptor tyrosine kinase EphA7 in gastric carcinoma and its clinical significances
受体酪氨酸激酶EphA7基因在胃癌中的表达及意义
10.
Effect of Receptor Protein-tyrosine Kinases in Tumor Angiogenesis
受体酪氨酸激酶在肿瘤血管新生中的作用
11.
Progress in research of multi-targeted inhibitors of receptor tyrosine kinase
多靶点受体酪氨酸激酶抑制剂的研究进展
12.
Preparation of Monoclonal Antibodies Against RON Receptor Tyrosine Kinase;
抗RON受体酪氨酸激酶单克隆抗体的制备和生物学特性研究
13.
The inhibitor of VEGF receptor tyrosine kinase was introduced in detail.
详细介绍了VEGF受体酪氨酸激酶抑制剂的研究进展。
14.
The Effect of Receptor Tyrosine Kinase Inhibitor on Repair Tissue in Chondrocyte and Osteoarthritis Cartilage;
受体酪氨酸激酶抑制剂在软骨修复中的作用研究
15.
Prevalence and Clinical Significance of Type Ⅲ Receptor Tyrosine Kinases in Acute Leukemia;
Ⅲ型受体酪氨酸激酶与急性白血病的关系及临床意义
16.
Experimental Studies on Rat Bone Marrow Stromal Cells Modified with Protein-tyrosine Kinase Receptor B Gene;
蛋白酪氨酸激酶受体B基因修饰骨髓基质细胞的实验研究
17.
The Experimental Study on the Effect of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor on Polycystic Kidney Disease;
表皮生长因子受体酪氨酸激酶抑制剂治疗多囊肾病的实验研究
18.
Expression and Mutational Analysis of Receptor of Tyrosine Kinase in Neuroendocrine Lung Carcinoma;
酪氨酸激酶受体表达、突变与肺神经内分泌癌患者临床预后关系